Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Fallopian Tube Neoplasms 8Ovarian Neoplasms 6Neoplasm Metastasis 5Breast Neoplasms 5Prostatic Neoplasms 4Triple Negative Breast Neoplasms 3Glioma 3Endometrial Neoplasms 3Wilms Tumor 2Small Cell Lung Carcinoma 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Pancreatic Neoplasms 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Glioblastoma 2Ependymoma 2Cholangiocarcinoma 2Central Nervous System Neoplasms 2Xanthogranuloma, Juvenile 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Sarcoma, Ewing 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1

Interventions

Cyclophosphamide 10Docetaxel 6Trastuzumab 5Radiotherapy 5Tamoxifen 4Neoadjuvant Therapy 4Filgrastim 4Doxorubicin 4tipifarnib 3Peripheral Blood Stem Cell Transplantation 3Epirubicin 3Thiotepa 2Radiation 2Paclitaxel 2Fluorouracil 2Chemotherapy, Adjuvant 2Carboplatin 2Capecitabine 2Bevacizumab 2pegfilgrastim 1olaparib 1cediranib 1aldesleukin 1Therapeutics 1Taxes 1Specimen Handling 1Razoxane 1Methotrexate 1Mesna 1Interleukin-12 Subunit p35 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Inflammatory Breast Neoplasms × olaparib × Clear all
NCT03598257 2026-05-13

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
300 enrolled
Breast

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡